Internal Medicine

3151 questions

Question 701Question →

A 38-year-old mechanic presents to the urgent care clinic complaining of severe flank pain, nausea, and blurry vision that started earlier this morning. He admits to accidentally ingesting a few mouthfuls of a liquid from an unmarked container in his garage while working late last night. His temperature is 36.8°C (98.2°F), blood pressure is 142/88 mm Hg, pulse is 98/min, and respiratory rate is 22/min. Cardiopulmonary examination is unremarkable. Initial laboratory tests reveal the following:

* Serum sodium: 138 mEq/L138 \text{ mEq/L}
* Serum potassium: 4.5 mEq/L4.5 \text{ mEq/L}
* Serum chloride: 104 mEq/L104 \text{ mEq/L}
* Serum bicarbonate: 14 mEq/L14 \text{ mEq/L}
* Blood urea nitrogen (BUN): 28 mg/dL28 \text{ mg/dL}
* Serum glucose: 126 mg/dL126 \text{ mg/dL}
* Measured serum osmolality: 315 mOsm/kg H2O315 \text{ mOsm/kg H}_2\text{O}

Based on these findings, what is the patient's calculated serum osmolar gap?

Show answer & explanation

Answer: 22

Answer

22
The calculated serum osmolality is derived using the formula 2×[Na+]+[Glucose]18+[BUN]2.82 \times [\text{Na}^+] + \frac{[\text{Glucose}]}{18} + \frac{[\text{BUN}]}{2.8}. Substituting the patient's values yields 2×138+12618+282.8=276+7+10=293 mOsm/kg H2O2 \times 138 + \frac{126}{18} + \frac{28}{2.8} = 276 + 7 + 10 = 293 \text{ mOsm/kg H}_2\text{O}. The osmolar gap is the measured osmolality minus the calculated osmolality (315−293=22 mOsm/kg H2O315 - 293 = 22 \text{ mOsm/kg H}_2\text{O}). A normal osmolar gap is typically less than 10-12; an elevated gap in this clinical context strongly supports the diagnosis of toxic alcohol ingestion (e.g., methanol or ethylene glycol).

Step-by-Step Solution

1
Determine the formula for calculated serum osmolality.
Calculated Osmolality = 2 × [Na+] + [Glucose]/18 + [BUN]/2.8
This standard formula accounts for the major osmotically active solutes in the extracellular fluid in the United States unit system (mg/dL).
2
Insert the patient's laboratory values into the formula.
Calculated Osmolality = (2 × 138) + (126 / 18) + (28 / 2.8)
To compute the expected osmolality based on native physiological solutes.
3
Perform the arithmetic for each component.
276 + 7 + 10 = 293 mOsm/kg H2O
Resolving the equation yields the total calculated osmolality.
4
Calculate the osmolar gap.
Measured Osmolality (315) - Calculated Osmolality (293) = 22 mOsm/kg H2O
The osmolar gap represents the presence of unmeasured osmotically active substances, such as toxic alcohols (e.g., methanol, ethylene glycol).

Key Concept

Calculation and clinical application of the serum osmolar gap in evaluating suspected toxic alcohol ingestion.
Question 702Question →

A 74-year-old man is admitted to the hospital with a 3-day history of progressively worsening shortness of breath, orthopnea, and lower extremity swelling. Physical examination reveals elevated jugular venous pressure, bilateral crackles at the lung bases, and 2+ pitting edema. Arterial blood gas on room air shows a pH of 7.48, PaCO 2_2 of 28 mm Hg, and HCO 3−_3^- of 20 mEq/L. The patient is started on intravenous furosemide. A routine admission laboratory panel is drawn, including thyroid function tests, which reveal the following:

Laboratory TestResultReference Range
Thyroid-stimulating hormone (TSH)0.1 μ\muU/mL0.4 - 4.0 μ\muU/mL
Free thyroxine (T4)1.1 ng/dL0.9 - 1.7 ng/dL
Total triiodothyronine (T3)55 ng/dL80 - 200 ng/dL

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassess thyroid function tests 4 to 6 weeks after hospital discharge

Answer

Reassess thyroid function tests 4 to 6 weeks after hospital discharge
The correct answer is to reassess thyroid function tests 4 to 6 weeks after hospital discharge. This patient is presenting with acute decompensated heart failure and has laboratory findings consistent with euthyroid sick syndrome (also known as non-thyroidal illness syndrome). This condition is characterized by abnormal thyroid function tests in the setting of a severe acute non-thyroidal illness. The most classic and earliest finding is a low total T3 level, caused by a decrease in the peripheral conversion of T4 to T3 via 5'-deiodinase. Free T4 typically remains normal, and TSH can be normal, mildly decreased, or mildly elevated depending on the phase of the illness. Because this is considered a physiologic adaptation to severe stress rather than true hypothyroidism, treatment with thyroid hormone replacement is not indicated and does not improve outcomes. The most appropriate management is to treat the underlying acute illness (heart failure) and reassess the thyroid panel several weeks after the patient has completely recovered.

Step-by-Step Solution

1
Analyze the clinical presentation and acid-base status.
The patient has acute decompensated heart failure with volume overload, leading to hypoxia and a primary respiratory alkalosis (elevated pH, low PaCO2).
Establishing the severity and nature of the primary acute illness is essential before interpreting secondary laboratory findings.
2
Interpret the thyroid laboratory profile in the context of the acute illness.
The profile shows a low T3, normal free T4, and slightly suppressed TSH.
This pattern must be differentiated from true primary or central thyroid disease.
3
Formulate a diagnosis for the thyroid abnormalities.
The findings are consistent with euthyroid sick syndrome (non-thyroidal illness syndrome).
During severe illness, peripheral conversion of T4 to T3 decreases, resulting in low T3 levels. TSH may also be transiently suppressed.
4
Determine the appropriate management.
No thyroid-specific pharmacological intervention is needed; repeat testing after recovery is recommended.
Thyroid hormone supplementation in euthyroid sick syndrome has not been shown to improve outcomes and may be harmful.

Key Concept

Euthyroid Sick Syndrome (Non-thyroidal Illness Syndrome)
Estimated Time:1m 15s
Question 703Question →

A 5858-year-old male presents to the outpatient clinic reporting a 55-month history of profound fatigue, anorexia, a 44-kg (8.88.8-lb) weight loss, and loss of libido. He also notes mild shortness of breath when climbing stairs and trace swelling in his ankles. Vital signs are temperature 36.636.6°C (97.997.9°F), blood pressure 95/6095/60 mm Hg, pulse 5454/min, and respirations 1616/min. Pulse oximetry is 96%96\% on room air. Physical examination reveals pale skin with no visible hyperpigmentation. Genitourinary examination shows soft, atrophic testes. Neurologic examination demonstrates a delayed relaxation phase of the Achilles tendon reflexes. Trace bilateral pitting edema is present. Lungs are clear to auscultation.

Laboratory evaluation reveals:

Laboratory TestResultReference Range
Sodium132132 mEq/L136136-145145 mEq/L
Potassium4.24.2 mEq/L3.53.5-5.05.0 mEq/L
Chloride9898 mEq/L9595-105105 mEq/L
Bicarbonate1616 mEq/L2222-2828 mEq/L
Blood glucose6868 mg/dL7070-9999 mg/dL
TSH0.80.8 μ\muU/mL0.50.5-5.05.0 μ\muU/mL
Free T40.30.3 ng/dL0.90.9-1.71.7 ng/dL

Arterial blood gas (room air):
pH: 7.337.33
PaCO 2_2: 3131 mm Hg
PaO 2_2: 8888 mm Hg

Urinalysis shows 88 WBCs/hpf, trace leukocyte esterase, negative nitrites, and no bacteria.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measure serum morning cortisol and adrenocorticotropic hormone levels

Answer

The most appropriate next step is to measure serum morning cortisol and adrenocorticotropic hormone (ACTH) levels.
The correct next step in management is assessing the adrenal axis. This patient presents with classic signs of panhypopituitarism: central hypothyroidism (low free T4 with inappropriately normal TSH), central adrenal insufficiency (hypotension, hypoglycemia, hyponatremia, fatigue, weight loss, and pale skin without hyperpigmentation), and central hypogonadism (atrophic testes, loss of libido). When a patient has multiple pituitary deficiencies, the order of hormone replacement is critical. Thyroid hormone enhances the basal metabolic rate and increases the hepatic clearance of cortisol. If levothyroxine is administered to a patient with unrecognized or untreated adrenal insufficiency, the sudden increased clearance of their marginal cortisol reserves can precipitate a life-threatening acute adrenal crisis. Therefore, clinicians must always assess morning cortisol and ACTH levels (and initiate hydrocortisone if indicated) before starting thyroid replacement.

Step-by-Step Solution

1
Analyze the thyroid laboratory results in the context of the clinical presentation.
The patient has a markedly low free T4 (0.30.3 ng/dL) but an inappropriately normal TSH (0.80.8 μ\mu U/mL), which confirms the diagnosis of central (secondary) hypothyroidism rather than primary hypothyroidism.
Identifying the central origin of the hypothyroidism redirects the differential diagnosis toward hypothalamic or pituitary pathology (e.g., panhypopituitarism) rather than intrinsic thyroid disease.
2
Synthesize the remaining clinical data to evaluate for other pituitary hormone deficiencies.
The patient exhibits profound fatigue, weight loss, hypotension (95/6095/60 mm Hg), hypoglycemia (6868 mg/dL), and hyponatremia (132132 mEq/L) without hyperpigmentation, strongly suggesting concurrent central adrenal insufficiency. The atrophic testes and loss of libido indicate central hypogonadism.
Recognizing panhypopituitarism is critical because multiple endocrine axes are affected simultaneously, altering the standard treatment approach for isolated deficiencies.
3
Determine the therapeutic sequence for replacing multiple missing pituitary hormones.
Cortisol levels must be evaluated (and replaced if deficient) prior to initiating thyroid hormone replacement.
Thyroid hormone increases the hepatic clearance of cortisol. In a patient with unrecognized and untreated adrenal insufficiency, starting levothyroxine will rapidly clear their remaining trace cortisol, precipitating a potentially fatal acute adrenal crisis.

Key Concept

In patients with suspected central hypothyroidism (panhypopituitarism), the adrenal axis must be evaluated with morning cortisol and ACTH levels before initiating levothyroxine to prevent precipitating an acute adrenal crisis.
Estimated Time:1m 30s
Question 704Question →

A 2424-year-old man is brought to the emergency department by his roommate after being found distressed and complaining of a 'loud ringing' in his ears. The patient has been experiencing nausea and vomited once prior to arrival. The roommate reports finding several empty bottles of over-the-counter pain relievers in their shared bathroom. His temperature is 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), blood pressure is 118/76118/76 mm Hg, pulse is 112112/min, and respiratory rate is 2828/min. Physical examination reveals a diaphoretic and anxious patient with deep, rapid respirations.

Laboratory results:
TestResult
Serum sodium140140 mEq/L
Serum potassium4.04.0 mEq/L
Serum chloride104104 mEq/L
Serum bicarbonate1414 mEq/L
Blood urea nitrogen1818 mg/dL
Serum creatinine1.11.1 mg/dL
Arterial blood gas on room air:
TestResult
pH7.477.47
PaCO22020 mm Hg
PaO29898 mm Hg

Based on the laboratory findings, which of the following best describes this patient's acid-base status?

Show answer & explanation

Answer: Mixed high anion gap metabolic acidosis and respiratory alkalosis

Answer

Mixed high anion gap metabolic acidosis and respiratory alkalosis
This patient's clinical presentation (tinnitus, nausea, tachypnea, empty pain reliever bottles) strongly suggests salicylate toxicity, which classically causes a mixed acid-base disorder. The calculated anion gap is 22 mEq/L (140−[104+14]140 - [104 + 14]), confirming a primary high anion gap metabolic acidosis. To determine if the respiratory response is appropriate, Winter's formula is applied: Expected PaCO2 = (1.5×14)+8=29±2(1.5 \times 14) + 8 = 29 \pm 2 mm Hg. The patient's actual PaCO2 is 20 mm Hg, which is significantly lower than the expected compensatory value. This indicates a concurrent primary respiratory alkalosis. Furthermore, the delta gap (Excess AG = 22−12=1022 - 12 = 10) equals the delta bicarbonate (24−14=1024 - 14 = 10), yielding a ratio of 1.0, which rules out any superimposed metabolic alkalosis or non-gap acidosis.

Step-by-Step Solution

1
Calculate the anion gap to determine if a primary metabolic acidosis is present.
Anion Gap = Na - (Cl + HCO3) = 140 - (104 + 14) = 22 mEq/L.
An anion gap > 12 mEq/L confirms the presence of a high anion gap metabolic acidosis.
2
Apply Winter's formula to calculate the expected PaCO2 for appropriate respiratory compensation.
Expected PaCO2 = (1.5 x 14) + 8 = 29 mm Hg (range: 27-31 mm Hg).
This determines if the respiratory response is merely compensatory or represents a separate primary disorder.
3
Compare the actual PaCO2 to the expected PaCO2.
The actual PaCO2 of 20 mm Hg is less than the expected range of 27-31 mm Hg.
Because the actual PaCO2 is driven lower than expected, there is a concomitant primary respiratory alkalosis.
4
Calculate the delta gap and delta ratio to evaluate for a third, hidden metabolic disorder.
Delta AG = 22 - 12 = 10. Delta HCO3 = 24 - 14 = 10. Delta ratio = 10 / 10 = 1.0.
A delta ratio between 1.0 and 2.0 indicates a pure high anion gap metabolic acidosis, ruling out concurrent metabolic alkalosis or non-gap metabolic acidosis.

Key Concept

Salicylate toxicity classically presents with a mixed acid-base disorder: a primary respiratory alkalosis (due to direct medullary respiratory center stimulation) and a primary high anion gap metabolic acidosis (due to uncoupling of oxidative phosphorylation and accumulation of organic acids).
Estimated Time:1m 30s
Question 705Question →

A 74-year-old woman arrives at the emergency department accompanied by her daughter. She complains of rapidly worsening shortness of breath and a cough producing pink, frothy sputum over the past 12 hours. She has a medical history significant for essential hypertension, diet-controlled type 2 diabetes mellitus, and a 45-pack-year smoking history. Her current daily medications are amlodipine and metformin.

Vital signs are as follows:
- Temperature: 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F})
- Blood pressure: 210/115 mmHg210/115 \text{ mmHg}
- Pulse: 118/min118/\text{min}
- Respiratory rate: 30/min30/\text{min}
- Oxygen saturation: 84%84\% on room air

Physical examination reveals a somnolent patient in severe respiratory distress, using accessory muscles of respiration. Jugular venous distention is prominent when the patient is seated upright. Lung auscultation reveals diffuse expiratory wheezes and coarse crackles extending from the bases to the mid-lung fields bilaterally. Cardiac auscultation demonstrates tachycardia, a regular rhythm, and a loud third heart sound (S3). Bilateral 2+ pitting edema is noted in the lower extremities.

Laboratory and arterial blood gas studies on room air reveal the following:
- Leukocyte count: 8,200/mm38,200/\text{mm}^3
- Serum creatinine: 1.3 mg/dL1.3 \text{ mg/dL}
- Thyroid-stimulating hormone (TSH): 1.2 μU/mL1.2 \,\mu\text{U/mL} (Normal: 0.5−5.0 μU/mL0.5 - 5.0 \,\mu\text{U/mL})
- Free T4: 0.7 ng/dL0.7 \text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL})
- pH: 7.227.22
- PaCO 2_2: 70 mmHg70 \text{ mmHg}
- PaO 2_2: 50 mmHg50 \text{ mmHg}
- HCO 3−_3^-: 27 mEq/L27 \text{ mEq/L}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous furosemide and noninvasive positive-pressure ventilation

Answer

Intravenous furosemide and noninvasive positive-pressure ventilation
The correct answer combines noninvasive positive-pressure ventilation (NPPV) and intravenous loop diuretics. This patient is in acute decompensated heart failure with flash pulmonary edema, evidenced by her severe hypertension, S3 gallop, JVD, and frothy sputum. NPPV decreases the work of breathing, improves oxygenation, and beneficially decreases both cardiac preload and afterload. Furosemide induces diuresis to reduce overall volume overload.

Step-by-Step Solution

1
Evaluate the clinical presentation and physical exam findings.
The patient presents with sudden severe respiratory distress, marked hypertension (210/115 mmHg210/115 \text{ mmHg}), jugular venous distention, crackles, an S3 gallop, and pink frothy sputum.
These findings are classic for acute decompensated heart failure (ADHF) presenting as 'flash' pulmonary edema.
2
Interpret the arterial blood gas (ABG) and laboratory results.
The ABG shows an acute respiratory acidosis (pH 7.227.22, PaCO 2_2 70 mmHg70 \text{ mmHg}) and severe hypoxemia due to impaired gas exchange from alveolar fluid. The thyroid panel shows a low free T4 with a normal TSH, indicating euthyroid sick syndrome.
Understanding the ABG prevents inappropriate acid-base interventions, and correctly identifying euthyroid sick syndrome prevents unnecessary hormone replacement.
3
Determine the most appropriate immediate intervention.
The correct management is a combination of loop diuretics (e.g., intravenous furosemide), vasodilators (e.g., nitroglycerin, given her severe hypertension), and noninvasive positive-pressure ventilation (NPPV).
NPPV reduces both preload and afterload while driving fluid out of the alveoli, improving oxygenation and hypercapnia. Furosemide provides rapid volume reduction.

Key Concept

The recognition and acute management of acute decompensated heart failure (ADHF) and cardiogenic pulmonary edema using diuretics, vasodilators, and noninvasive positive-pressure ventilation.
Question 706Question →

A first-year internal medicine resident sustains a deep, bleeding needlestick injury to their index finger while drawing arterial blood from a patient with known, poorly controlled HIV infection. Arrange the following steps in the most appropriate chronological sequence for managing this occupational exposure.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Wash the puncture site, 2) Report the incident to occupational health, 3) Draw baseline blood for serology, and 4) Initiate the post-exposure prophylaxis regimen.
The standard sequence for managing an occupational exposure to bloodborne pathogens begins with immediate local first aid (washing with soap and water) to reduce the viral inoculum. This is followed by reporting the incident to occupational health to activate institutional protocols. Next, baseline serology and safety labs are drawn from the exposed healthcare worker. Finally, a three-drug antiretroviral PEP regimen is initiated as soon as possible, ideally within 1 to 2 hours of the exposure.

Step-by-Step Solution

1
Perform immediate local first aid.
The puncture site is washed with soap and water.
Physical removal of blood and bodily fluids reduces the viral inoculum and risk of transmission. This must be done immediately.
2
Activate the exposure protocol.
The incident is reported to occupational health or the designated emergency personnel.
Institutional protocols ensure standardized testing, proper documentation, and immediate access to prophylactic antiretroviral medications.
3
Perform baseline evaluation.
Baseline HIV, HBV, and HCV serologies, along with safety labs, are drawn from the exposed resident.
Baseline testing is necessary to document the worker's pre-existing infectious status and organ function before starting potentially toxic PEP medications.
4
Administer empiric therapy.
A three-drug antiretroviral post-exposure prophylaxis (PEP) regimen is initiated.
PEP is most effective when started as soon as possible, ideally within 1-2 hours of the exposure. It should not be delayed while awaiting lab results.

Key Concept

Occupational HIV exposure management sequence
Estimated Time:1m 0s
Question 707Question →

Match each patient's clinical presentation and cerebrospinal fluid (CSF) analysis findings with the most appropriate targeted or empiric treatment regimen.

Click a left item, then click its matching right item

Items

A 22-year-old college student presents with fever, severe headache, nuchal rigidity, and a petechial rash. CSF reveals 1200 WBCs/µL (90% neutrophils), glucose 25 mg/dL, and protein 150 mg/dL.
A 65-year-old man presents with acute fever, confusion, and new-onset focal seizures. CSF reveals 150 WBCs/µL (95% lymphocytes), glucose 65 mg/dL, protein 80 mg/dL, and numerous erythrocytes.
A 45-year-old woman with advanced HIV (CD4 count = 30 cells/mm³) presents with subacute headache and lethargy. CSF reveals an opening pressure of 350 mm H2O, 50 WBCs/µL (90% lymphocytes), glucose 30 mg/dL, and protein 100 mg/dL.
A 30-year-old man recently emigrated from a highly endemic region presents with a 3-week history of low-grade fever, weight loss, and cranial nerve VI palsy. CSF reveals 300 WBCs/µL (predominantly lymphocytes), glucose 20 mg/dL, and protein 250 mg/dL.

Matches

Show answer & explanation

Answer

The correct pairings match each central nervous system infection's classic clinical phenotype and cerebrospinal fluid profile to its definitive or empiric antimicrobial therapy (bacterial to ceftriaxone/vancomycin, viral HSV to acyclovir, fungal cryptococcal to amphotericin/flucytosine, and mycobacterial to RIPE+steroids).
Each matching pair requires recognizing the classic clinical phenotype and CSF profile of a specific CNS infection to select the correct corresponding antimicrobial therapy. Bacterial meningitis presents with neutrophilic pleocytosis and hypoglycorrhachia. HSV encephalitis typically causes temporal lobe necrosis leading to RBCs in the CSF with a lymphocytic pleocytosis. Cryptococcal meningitis is associated with high opening pressures in immunocompromised hosts. TB meningitis typically presents subacutely with cranial nerve palsies, profound hypoglycorrhachia, and extremely high protein.

Step-by-Step Solution

1
Analyze the CSF profile and clinical presentation for the 22-year-old student.
Identification of a neutrophilic pleocytosis with low glucose and petechial rash, indicative of bacterial meningitis.
This classical presentation dictates immediate empiric therapy with broad-spectrum antibacterials covering S. pneumoniae and N. meningitidis.
2
Evaluate the 65-year-old man with confusion, seizures, and CSF erythrocytes.
Diagnosis of suspected HSV encephalitis, which requires empiric intravenous acyclovir.
Erythrocytes in a lymphocytic, normal-glucose CSF profile strongly suggest the hemorrhagic temporal lobe necrosis typical of HSV.
3
Assess the HIV-positive patient with an extremely high CSF opening pressure.
Diagnosis of cryptococcal meningitis, necessitating induction therapy with amphotericin B and flucytosine.
Cryptococcus uniquely causes severe intracranial hypertension with a mild lymphocytic pleocytosis in immunocompromised hosts.
4
Review the subacute presentation of cranial nerve palsy and highly elevated CSF protein in the immigrant patient.
Diagnosis of tuberculous meningitis, requiring RIPE therapy and dexamethasone.
Basilar exudates causing cranial neuropathies alongside subacute lymphocytic meningitis are the hallmark of CNS tuberculosis.

Key Concept

Cerebrospinal fluid (CSF) analysis interpretation and appropriate empiric therapy for central nervous system infections
Question 708Question →

An oncologist is called to the emergency department to evaluate a 6262-year-old male patient who has developed profound lethargy, severe nausea, and diffuse myalgias over the past 55 days. The patient was diagnosed with metastatic non-small cell lung cancer six months ago and is currently receiving combination immunotherapy with nivolumab and ipilimumab.

Vital signs are as follows: temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 82/50 mmHg82/50\text{ mmHg}, heart rate is 115/min115/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination shows dry mucous membranes, clear lungs to auscultation, and no cutaneous hyperpigmentation.

Laboratory evaluation reveals:
Sodium\text{Sodium}: 129 mEq/L129\text{ mEq/L}
Potassium\text{Potassium}: 4.1 mEq/L4.1\text{ mEq/L}
Glucose\text{Glucose}: 58 mg/dL58\text{ mg/dL}
Eosinophils\text{Eosinophils}: 8%8\%
Thyroid-stimulating hormone (TSH)\text{Thyroid-stimulating hormone (TSH)}: 0.1 \muU/mL0.1\text{ \mu U/mL} (Normal: 0.5−5.0 \muU/mL0.5-5.0\text{ \mu U/mL})
Free T4\text{Free T4}: 0.4 ng/dL0.4\text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL})

An 8 AM8\text{ AM} serum cortisol level has been drawn and is pending.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous hydrocortisone and isotonic normal saline

Answer

Administer intravenous hydrocortisone and isotonic normal saline
The correct answer addresses the patient's acute adrenal crisis caused by immune checkpoint inhibitor-induced hypophysitis. Ipilimumab and nivolumab are notorious for causing immune-related adverse events (irAEs), including inflammation of the pituitary gland. This results in the loss of anterior pituitary hormones, leading to secondary adrenal insufficiency (causing hypotension, hypoglycemia, hyponatremia, and eosinophilia) and secondary hypothyroidism (low TSH and low Free T4). The patient is in hypovolemic and vasodilatory shock due to a lack of cortisol. The absolute rule of endocrine replacement therapy in panhypopituitarism or combined deficiencies is that glucocorticoids (e.g., hydrocortisone) must always be replaced before thyroid hormone. Administering thyroid hormone first increases the basal metabolic rate, accelerating the clearance of any remaining cortisol and precipitating a fatal adrenal crisis. Therefore, immediate administration of intravenous hydrocortisone and isotonic normal saline is the critical next step.

Step-by-Step Solution

1
Identify the primary complication of the patient's immunotherapy.
The patient is experiencing immune checkpoint inhibitor-induced hypophysitis.
Nivolumab (anti-PD-1) and ipilimumab (anti-CTLA-4) frequently cause immune-related adverse events. The combination of severe hypotension, hyponatremia, hypoglycemia, and inappropriately low TSH/Free T4 points directly to inflammation and failure of the anterior pituitary gland.
2
Analyze the laboratory data to determine the specific endocrine deficits.
The laboratories confirm secondary hypothyroidism and strongly suggest concurrent secondary adrenal insufficiency.
A low Free T4 accompanied by a low TSH indicates central hypothyroidism. Furthermore, the hyponatremia, hypoglycemia, eosinophilia, and hemodynamic instability in this clinical context are classic indicators of an acute adrenal crisis (cortisol deficiency).
3
Determine the correct sequencing of life-saving hormone replacement therapy.
Glucocorticoids (hydrocortisone) must be administered immediately, prior to any thyroid hormone replacement.
Administering levothyroxine increases the basal metabolic rate, which accelerates the hepatic clearance of the patient's remaining endogenous cortisol. In a state of adrenal insufficiency, this will precipitate or worsen a fatal adrenal crisis.

Key Concept

Diagnosis and management sequencing of immune checkpoint inhibitor-induced hypophysitis (central hypothyroidism and secondary adrenal insufficiency).
Estimated Time:2m 0s
Question 709Question →

A 45-year-old female patient with newly diagnosed acute myeloid leukemia is currently undergoing induction chemotherapy in the oncology unit. On the tenth day of her treatment course, her body temperature spikes to 38.6°C (101.5°F). Vital signs show a blood pressure of 105/65 mm Hg, a heart rate of 110/min, and respirations of 18/min. She has a tunneled central venous catheter in place. Physical examination reveals no focal signs of infection; her lungs are clear to auscultation, and the catheter site exhibits no erythema or purulent discharge. Laboratory evaluation is notable for a leukocyte count of 400/mm³ with 10% neutrophils, resulting in an absolute neutrophil count of 40/mm³. A diagnosis of high-risk neutropenic fever is established.

Arrange the following clinical steps in the correct chronological sequence for the standard evaluation and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing high-risk neutropenic fever is: 1) Obtain blood cultures, 2) Initiate empiric antipseudomonal antibiotics, 3) Reassess at 48-72 hours, and 4) Add empiric antifungals if fever persists for 4-7 days.
The management of high-risk neutropenic fever relies on a strict, time-sensitive algorithm to minimize mortality. The sequence begins with identifying the potential pathogen by obtaining blood cultures from all lines to avoid altering the yield of the cultures. Immediately following culture collection, patients must receive broad-spectrum empiric antibiotics that cover Pseudomonas aeruginosa because bacterial infections are the most common and immediately life-threatening complications. At 48-72 hours, the initial regimen is formally reassessed based on the patient's clinical trajectory and preliminary culture results, allowing for de-escalation or targeted adjustments. Finally, if the patient remains persistently febrile after 4-7 days of appropriate antibacterial coverage without an identified source, the likelihood of an invasive fungal infection (such as candidiasis or aspergillosis) rises significantly, which warrants the addition of empiric systemic antifungal therapy.

Step-by-Step Solution

1
Obtain blood cultures
Samples are secured for pathogen identification before drug interference.
Administering antibiotics before drawing cultures can sterilize the blood samples, preventing the identification of the organism and hindering targeted therapy.
2
Administer empiric antipseudomonal antibiotics
Broad-spectrum antibacterial coverage is immediately established.
Neutropenic patients lack the immune response to contain bacterial infections, making rapid initiation of therapy critical for survival.
3
Clinical and microbiological reassessment
Therapy is guided by 48-72 hour culture results and clinical status.
It typically takes 2 to 3 days for bacterial cultures to grow and for the patient to demonstrate a definitive clinical response to the initial empiric regimen.
4
Initiate empiric antifungal therapy
Coverage is expanded to treat potential invasive fungal pathogens.
Persistent fever in a profoundly neutropenic patient after 4 to 7 days of broad-spectrum antibacterial therapy is highly suggestive of an occult fungal infection.

Key Concept

The chronological management of high-risk neutropenic fever requires immediate culture acquisition, followed instantly by antipseudomonal antibacterial therapy, a formal reassessment at 48-72 hours, and the addition of antifungal therapy only if fevers persist beyond 4-7 days.
Estimated Time:1m 30s
Question 710Question →

Emergency medical responders bring a 5353-year-old male to the emergency department due to severe, acute-onset respiratory distress. The patient's spouse reports he has been unable to sleep lying flat for the past two nights and has been coughing frequently. His medical history is significant for poorly controlled hypertension, type 22 diabetes mellitus, and a 3030-pack-year smoking history. On arrival, he is sitting on the edge of the stretcher, diaphoretic, and using accessory muscles to breathe. Vital signs include a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 192/108 mmHg192/108\text{ mmHg}, heart rate of 118/min118/\text{min}, and respiratory rate of 30/min30/\text{min}. Pulse oximetry shows an oxygen saturation of 84%84\% on room air. Physical examination reveals prominent jugular venous distention measuring 10 cm H2O10\text{ cm H}_2\text{O} above the sternal angle. Auscultation of the lungs reveals diffuse expiratory wheezes and scattered crackles in the lower two-thirds of both lung fields. A bedside electrocardiogram demonstrates sinus tachycardia with left ventricular hypertrophy but no acute ST-segment changes. Which of the following is the most appropriate initial step in management?

Show answer & explanation

Answer: Intravenous furosemide and noninvasive positive-pressure ventilation

Answer

Intravenous furosemide and noninvasive positive-pressure ventilation
The correct answer addresses both the acute hypoxic respiratory failure and the volume overload defining this patient's acute decompensated heart failure (ADHF). The patient's clinical picture of extreme hypertension, jugular venous distention, orthopnea, crackles, and wheezing represents 'flash' pulmonary edema with cardiac asthma (peribronchial edema). Noninvasive positive-pressure ventilation (NPPV) provides immediate positive end-expiratory pressure, which drives fluid out of the alveoli and significantly reduces both left ventricular preload and afterload. Concurrent administration of an intravenous loop diuretic (like furosemide) provides necessary diuresis to treat the total body volume overload.

Step-by-Step Solution

1
Analyze the patient's presentation and vital signs.
The patient has acute, severe hypoxia (84%84\%), significant hypertension (192/108 mmHg192/108\text{ mmHg}), orthopnea, jugular venous distention, crackles, and wheezing.
Identifying the primary physiological derangement (respiratory failure with severe hypertension and right-sided pressures) is essential for diagnosis.
2
Differentiate between primarily pulmonary (e.g., COPD) and cardiac causes of dyspnea with wheezing.
Despite the smoking history and wheezing, the prominent JVD, orthopnea, and severe hypertension confirm acute decompensated heart failure (ADHF) with 'cardiac asthma', rather than a primary COPD exacerbation.
Cardiac asthma occurs when peribronchial edema causes airway narrowing and wheezing; distinguishing this from true bronchospasm prevents therapeutic errors.
3
Determine the most appropriate initial stabilization step.
The patient requires immediate respiratory support and afterload/preload reduction, best achieved with noninvasive positive-pressure ventilation (NPPV) and an intravenous loop diuretic.
NPPV rapidly improves oxygenation, pushes alveolar fluid into the capillaries, and decreases both preload and afterload. Diuretics remove excess volume.

Key Concept

Patients with acute decompensated heart failure can present with 'cardiac asthma' (wheezing due to peribronchial edema); initial management involves immediate respiratory support with noninvasive positive-pressure ventilation and fluid offloading with loop diuretics.
Estimated Time:1m 0s
Question 711Question →

A 1919-year-old male college student presents to the emergency department accompanied by his roommate after developing a severe headache, confusion, and high fever over the previous 1212 hours. His temperature is 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), blood pressure is 108/68 mmHg108/68\text{ mmHg}, and heart rate is 118 beats/min118\text{ beats/min}. Physical examination reveals marked nuchal rigidity and a non-blanching petechial rash on his lower extremities. A lumbar puncture is performed, and empiric therapy with intravenous ceftriaxone, vancomycin, and dexamethasone is promptly initiated. Cerebrospinal fluid (CSF) analysis shows a leukocyte count of 3,200 cells/mm33,200\text{ cells/mm}^3 (92%92\% neutrophils), a glucose level of 22 mg/dL22\text{ mg/dL}, and a protein level of 165 mg/dL165\text{ mg/dL}. The following day, the patient's mental status improves. CSF culture grows *Neisseria meningitidis*. Antimicrobial susceptibility testing is pending. Which of the following is the most appropriate next step in this patient's antimicrobial management?

Show answer & explanation

Answer: Stop the vancomycin infusion and maintain the ceftriaxone.

Answer

Stop the vancomycin infusion and maintain the ceftriaxone.
The correct answer is to discontinue the vancomycin infusion and maintain the ceftriaxone. Empiric therapy for acute bacterial meningitis in immunocompetent adults between the ages of 22 and 5050 consists of a third-generation cephalosporin (e.g., ceftriaxone or cefotaxime) plus vancomycin. The sole purpose of adding vancomycin to this empiric regimen is to provide adequate coverage against highly penicillin-resistant strains of *Streptococcus pneumoniae*. Once cerebrospinal fluid cultures definitively identify *Neisseria meningitidis*, the risk of resistant *S. pneumoniae* is eliminated. Antimicrobial stewardship principles strongly dictate that broad-spectrum or additional agents should be discontinued (de-escalated) as soon as culture results allow. *N. meningitidis* is highly susceptible to ceftriaxone, which also boasts excellent central nervous system penetration. Therefore, maintaining ceftriaxone and stopping vancomycin is the most appropriate, targeted management.

Step-by-Step Solution

1
Analyze the patient's presentation and initial management.
The patient presented with classic signs of acute bacterial meningitis and was appropriately started on empiric ceftriaxone, vancomycin, and dexamethasone.
Empiric therapy must cover the most likely pathogens, including highly penicillin-resistant Streptococcus pneumoniae (covered by vancomycin) and Neisseria meningitidis (covered by ceftriaxone).
2
Evaluate the new culture data.
CSF culture has isolated Neisseria meningitidis.
Identifying the specific pathogen allows for targeted therapy, optimizing efficacy while minimizing toxicity and resistance.
3
Determine the appropriate modification to the antibiotic regimen based on stewardship principles.
Vancomycin is no longer needed because the pathogen is not S. pneumoniae. Ceftriaxone alone provides reliable coverage for N. meningitidis.
Discontinuing unnecessary broad-spectrum coverage (de-escalation) is a core component of antimicrobial stewardship.

Key Concept

In patients with acute bacterial meningitis, empiric vancomycin is used specifically to cover penicillin-resistant Streptococcus pneumoniae and should be discontinued once a different pathogen, such as Neisseria meningitidis, is identified.
Question 712Question →

A 42-year-old woman presents to her primary care physician reporting progressively worsening fatigue and cold intolerance over the past six months. She also notes that her menstrual periods, which were previously regular, ceased entirely eight months ago. Over the last several weeks, she has been experiencing intermittent, dull headaches. She takes no medications and has no significant past medical history.

Physical examination reveals a blood pressure of 110/70110/70 mmHg and a pulse of 5656/min. The thyroid gland is not palpable. Neurologic examination demonstrates delayed relaxation of the deep tendon reflexes. Confrontational visual field testing reveals a loss of peripheral vision in both temporal fields.

Laboratory studies show the following:

Laboratory ParameterPatient ValueReference Range
Prolactin7575 ng/mL4−234 - 23 ng/mL
Thyroid-stimulating hormone (TSH)2.12.1 μ\muU/mL0.4−4.00.4 - 4.0 μ\muU/mL
Free thyroxine (T4)0.50.5 ng/dL0.9−1.70.9 - 1.7 ng/dL
Urine pregnancy testNegativeNegative

Which of the following is the most likely underlying mechanism for this patient's clinical and laboratory findings?

Show answer & explanation

Answer: Disruption of dopaminergic pathways by a suprasellar mass

Answer

The presentation is caused by disruption of dopaminergic pathways by a suprasellar mass (pituitary stalk effect).
The correct answer identifies the 'stalk effect' caused by a non-functioning pituitary macroadenoma. This patient presents with mass effect symptoms (headache, bitemporal hemianopsia) indicating a large sellar lesion. The lesion compresses normal thyrotrophs, causing central hypothyroidism (low Free T4, normal TSH). Simultaneously, it compresses the pituitary stalk (infundibulum). Because prolactin secretion is uniquely regulated by tonic inhibition via hypothalamic dopamine, blocking the stalk prevents dopamine delivery, resulting in a mild elevation of prolactin (usually <100100 ng/mL) and subsequent amenorrhea.

Step-by-Step Solution

1
Interpret the thyroid function tests.
The patient has a low Free T4 (0.50.5 ng/dL) with an inappropriately normal TSH (2.12.1 μ\mu U/mL).
This specific laboratory pattern indicates central (secondary) hypothyroidism, pointing to a pituitary or hypothalamic origin rather than primary thyroid pathology.
2
Analyze the structural and neurological findings.
The patient has new-onset headaches and bitemporal hemianopsia.
These findings are classic for a mass lesion in the sella turcica compressing the optic chiasm, such as a pituitary macroadenoma.
3
Evaluate the prolactin level in the context of the mass lesion.
The prolactin is mildly elevated at 7575 ng/mL.
A prolactinoma large enough to cause visual field deficits would typically produce prolactin levels >200200 ng/mL. A mild elevation suggests the 'stalk effect', where a non-functioning mass compresses the infundibulum, blocking the delivery of inhibitory dopamine from the hypothalamus to the lactotrophs.

Key Concept

Non-functioning pituitary macroadenomas can cause central hypopituitarism (via tissue compression) and mild hyperprolactinemia (via pituitary stalk compression, known as the 'stalk effect').
Question 713Question →

A 65-year-old man presents to the outpatient clinic with a 4-day history of a productive cough, fevers, and progressively worsening shortness of breath. His medical history is significant for hypertension and type 2 diabetes mellitus, for which he takes lisinopril and metformin. His temperature is 38.4°C (101.1°F), blood pressure is 132/82 mm Hg, pulse is 98/min, and respiratory rate is 22/min. Pulse oximetry shows an oxygen saturation of 94% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. A chest radiograph demonstrates a dense consolidation in the right lower lobe. The physician determines the patient is stable for outpatient management. Which of the following is the most appropriate empiric pharmacotherapy for this patient?

Show answer & explanation

Answer: Amoxicillin-clavulanate and azithromycin

Answer

Amoxicillin-clavulanate and azithromycin
The correct answer provides the recommended combination therapy for an outpatient with community-acquired pneumonia (CAP) who has significant medical comorbidities (such as type 2 diabetes mellitus). According to current clinical guidelines, outpatients with comorbidities (e.g., chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancy; or asplenia) require expanded empiric coverage. This is typically achieved with combination therapy consisting of a beta-lactam (such as amoxicillin-clavulanate or cefpodoxime) PLUS a macrolide (such as azithromycin) or doxycycline. Alternatively, monotherapy with a respiratory fluoroquinolone (such as levofloxacin or moxifloxacin) can be used. The beta-lactam provides robust coverage against typical pathogens (e.g., Streptococcus pneumoniae, Haemophilus influenzae), while the macrolide provides coverage against atypical organisms (e.g., Mycoplasma pneumoniae, Chlamydia pneumoniae).

Step-by-Step Solution

1
Diagnose the patient's condition based on clinical presentation.
The patient has community-acquired pneumonia (CAP), evidenced by fever, productive cough, crackles, and a focal lobar consolidation on chest radiograph.
Establishing the correct infectious syndrome is required before selecting empiric antimicrobial therapy.
2
Stratify the patient's risk and determine the appropriate setting of care.
The patient has stable vital signs and oxygenation, permitting outpatient treatment. However, he has significant comorbidities (type 2 diabetes mellitus, hypertension).
The presence of comorbidities alters the expected pathogen profile and resistance patterns, dictating a different empiric antibiotic strategy compared to healthy individuals.
3
Select the appropriate empiric antibiotic regimen for an outpatient with CAP and comorbidities.
The recommended regimen is a beta-lactam (e.g., amoxicillin-clavulanate) combined with a macrolide (e.g., azithromycin) or doxycycline, OR monotherapy with a respiratory fluoroquinolone.
This strategy ensures adequate coverage against common typical pathogens (including macrolide-resistant Streptococcus pneumoniae and beta-lactamase producing Haemophilus influenzae) as well as atypical pathogens (Mycoplasma, Chlamydia, Legionella).

Key Concept

Empiric antibiotic selection for community-acquired pneumonia (CAP) in outpatients with comorbidities
Question 714Question →

A 5454-year-old man is hospitalized for the initiation of induction chemotherapy for a newly diagnosed high-grade non-Hodgkin lymphoma. Forty-eight hours after starting his chemotherapy regimen, he develops progressive lethargy, generalized muscle cramps, and two episodes of vomiting. His temperature is 37.2∘C37.2^\circ\text{C}, blood pressure is 105/65 mmHg105/65\text{ mmHg}, heart rate is 112/min112\text{/min}, and respiratory rate is 22/min22\text{/min}.

Laboratory studies reveal the following:

Laboratory TestResult
Potassium6.9 mEq/L6.9\text{ mEq/L}
Calcium6.1 mg/dL6.1\text{ mg/dL}
Phosphorus8.8 mg/dL8.8\text{ mg/dL}
Uric acid15.2 mg/dL15.2\text{ mg/dL}
Blood urea nitrogen48 mg/dL48\text{ mg/dL}
Creatinine2.9 mg/dL2.9\text{ mg/dL} (baseline 0.9 mg/dL0.9\text{ mg/dL})

An arterial blood gas analysis reveals a pH of 7.287.28, pCO2\text{pCO}_2 of 30 mmHg30\text{ mmHg}, and HCO3−\text{HCO}_3^- of 14 mEq/L14\text{ mEq/L}. An electrocardiogram demonstrates peaked T waves and a prolonged PR interval. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous calcium gluconate, vigorous hydration, and rasburicase

Answer

Administer intravenous calcium gluconate, vigorous hydration, and rasburicase
The correct answer involves immediate cardioprotection with calcium gluconate, followed by aggressive hydration and rasburicase. This patient is presenting with classic Tumor Lysis Syndrome (TLS), an oncologic emergency caused by massive tumor cell destruction following the initiation of cytotoxic therapy. The rapid breakdown of cells releases large amounts of intracellular potassium, phosphorus, and nucleic acids (which are metabolized to uric acid). The resulting hyperphosphatemia leads to secondary hypocalcemia as calcium binds to the excess phosphorus. The patient's electrocardiogram shows critical signs of hyperkalemia (peaked T waves and prolonged PR interval), making intravenous calcium gluconate the absolute most urgent first step to stabilize the cardiac membrane and prevent fatal arrhythmias. This must be given alongside aggressive intravenous hydration to maintain urine output and a potent urate-lowering agent like rasburicase to mitigate further acute kidney injury.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory results in the context of recent chemotherapy.
The combination of hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, and acute kidney injury 48 hours after starting chemotherapy points to Tumor Lysis Syndrome (TLS).
High-grade lymphomas are highly responsive to chemotherapy, leading to massive, rapid lysis of tumor cells and release of intracellular contents.
2
Evaluate the patient's electrocardiogram (ECG) and potassium levels.
The potassium is dangerously high (6.9 mEq/L6.9\text{ mEq/L}) with ECG changes (peaked T waves, prolonged PR interval).
ECG changes in the setting of hyperkalemia indicate imminent risk of fatal cardiac arrhythmias.
3
Determine the most appropriate immediate intervention based on the imminent threats to the patient's life.
The immediate priority is myocardial stabilization with intravenous calcium gluconate.
Calcium directly antagonizes the membrane actions of hyperkalemia without lowering the serum potassium level, buying time for therapies that drive potassium into cells or remove it from the body.
4
Identify the definitive management for the underlying pathophysiologic process of TLS.
The patient requires vigorous intravenous hydration and a urate-lowering agent such as rasburicase.
Hydration flushes the renal tubules, and rasburicase rapidly metabolizes existing uric acid into highly soluble allantoin, preventing further uric acid nephropathy and reversing the acute kidney injury.

Key Concept

Diagnosis and management of Tumor Lysis Syndrome (TLS)
Estimated Time:1m 30s
Question 715Question →

A 34-year-old woman presents to the clinic with a 2-day history of pinpoint red rashes on her lower extremities and bleeding from her gums when brushing her teeth. She reports having a mild upper respiratory infection two weeks ago but is otherwise healthy. She takes no medications and has no personal or family history of bleeding disorders. Vital signs are within normal limits. Physical examination reveals diffuse petechiae over the bilateral shins and ankles. There is no palpable hepatosplenomegaly, and no lymphadenopathy is appreciated. Neurologic examination is unremarkable.

Laboratory results are as follows:
Hemoglobin: 12.5 g/dL12.5 \text{ g/dL}
Leukocyte count: 7,500/mm37,500/\text{mm}^3
Platelet count: 14,000/mm314,000/\text{mm}^3
Prothrombin time: 11 seconds11 \text{ seconds}
Activated partial thromboplastin time: 28 seconds28 \text{ seconds}
Creatinine: 0.8 mg/dL0.8 \text{ mg/dL}

A peripheral blood smear shows enlarged platelets but no schistocytes or blasts. What is the most appropriate next step in management?

Show answer & explanation

Answer: Administer high-dose oral corticosteroids

Answer

Administer high-dose oral corticosteroids
The correct answer is to administer high-dose oral corticosteroids. This patient presents with primary immune thrombocytopenia (ITP), an autoimmune disorder characterized by IgG autoantibodies directed against platelet membrane glycoproteins (e.g., GPIIb/IIIa). This leads to increased platelet destruction by splenic macrophages and isolated thrombocytopenia. The diagnosis is clinical and supported by isolated thrombocytopenia, normal coagulation times, and a peripheral smear showing large platelets (indicating increased bone marrow production) without schistocytes. In adult patients, treatment is indicated if there is active bleeding or if the platelet count is <30,000/mm3< 30,000/\text{mm}^3. First-line therapy consists of high-dose glucocorticoids (such as dexamethasone or prednisone), which may be combined with intravenous immunoglobulin (IVIG) if a rapid increase in platelet count is required.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has isolated thrombocytopenia (14,000/mm314,000/\text{mm}^3) with normal hemoglobin, leukocytes, and coagulation studies. The peripheral smear shows large platelets without schistocytes.
To differentiate between potential causes of thrombocytopenia, such as ITP, TTP, DIC, and bone marrow failure.
2
Establish the most likely diagnosis.
The diagnosis is primary immune thrombocytopenia (ITP), triggered by a recent viral infection.
The isolated low platelet count, mucocutaneous bleeding, lack of splenomegaly, and absence of microangiopathic hemolytic anemia fit the classic presentation of ITP.
3
Determine the indication for treatment.
Treatment is indicated because the platelet count is <30,000/mm3< 30,000/\text{mm}^3 and the patient is experiencing active mucosal bleeding (gums).
Patients with ITP who have platelets <30,000/mm3< 30,000/\text{mm}^3 or significant clinical bleeding are at high risk for severe hemorrhage and require therapy.
4
Select the appropriate first-line therapy.
High-dose glucocorticoids (e.g., dexamethasone or prednisone) are selected.
Corticosteroids reduce autoantibody production and decrease splenic macrophage destruction of antibody-coated platelets, making them the standard initial treatment for ITP.

Key Concept

Diagnosis and management of primary immune thrombocytopenia (ITP)
Estimated Time:1m 0s
Question 716Question →

A 68-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) is admitted to the intensive care unit for acute hypercapnic respiratory failure and suspected community-acquired pneumonia. Upon arrival, he is hemodynamically stable but exhibits severe respiratory distress. Endotracheal intubation and mechanical ventilation are initiated. Shortly after intubation, his blood pressure drops to 78/45 mmHg and his heart rate increases to 122/min. Pulse oximetry shows 92% on an FiO2FiO_2 of 0.50. Physical examination reveals diffuse wheezing and right lower lobe crackles. A portable chest radiograph demonstrates hyperinflated lungs, a prominent right descending pulmonary artery, and a right lower lobe consolidation, without pulmonary venous congestion. Sputum Gram stain reveals numerous neutrophils and gram-positive, lancet-shaped diplococci. Bedside echocardiography shows a severely dilated right ventricle, a plethoric inferior vena cava, and systolic flattening of the interventricular septum (D-shaped left ventricle); the left ventricular ejection fraction is 65%. Arterial blood gas analysis on current ventilator settings reveals:

ParameterValue
pHpH7.18
PaCO2PaCO_270 mmHg
PaO2PaO_268 mmHg
HCO3−HCO_3^-26 mEq/L

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate a norepinephrine infusion and administer ceftriaxone

Answer

Initiate a norepinephrine infusion and administer ceftriaxone.
The correct answer combines the appropriate hemodynamic support for right ventricular (RV) failure with targeted antimicrobial stewardship. Positive pressure ventilation increases intrathoracic pressure, increasing RV afterload while simultaneously decreasing venous return. In a patient with baseline COPD and pneumonia (which causes hypoxemic pulmonary vasoconstriction), this leads to acute RV failure, manifested by the D-shaped left ventricle (interventricular septal bowing due to RV pressure overload) and obstructive shock. Because RV perfusion is driven by the gradient between the aorta and the RV, profound systemic hypotension causes RV ischemia, worsening the failure in a vicious cycle. Norepinephrine increases systemic mean arterial pressure, restoring the coronary perfusion gradient to the RV. Additionally, the sputum Gram stain specifically identifies *Streptococcus pneumoniae* (gram-positive lancet-shaped diplococci), making targeted therapy with ceftriaxone the most appropriate antimicrobial choice.

Step-by-Step Solution

1
Analyze the hemodynamic and echocardiographic findings.
Hypotension following intubation with a severely dilated right ventricle, plethoric IVC, and a 'D-shaped' left ventricle indicates acute right ventricular failure (cor pulmonale) leading to obstructive shock.
Positive pressure ventilation increases intrathoracic pressure, which increases right ventricular afterload and decreases venous return. In a patient with baseline pulmonary hypertension (COPD), this can acutely precipitate right heart failure.
2
Determine the optimal hemodynamic intervention.
Norepinephrine is indicated to increase systemic vascular resistance and mean arterial pressure.
The failing right ventricle relies heavily on the aortic root pressure (systemic pressure) to maintain its own coronary perfusion gradient. Norepinephrine supports systemic blood pressure without significantly increasing pulmonary vascular resistance.
3
Interpret the sputum Gram stain and select antimicrobial therapy.
Gram-positive, lancet-shaped diplococci indicate Streptococcus pneumoniae. Ceftriaxone provides excellent targeted coverage.
Selecting targeted therapy adheres to antimicrobial stewardship, avoiding unnecessary broad-spectrum agents.

Key Concept

Management of acute right ventricular failure in mechanically ventilated patients requires vasopressors to maintain right coronary perfusion, while avoiding interventions that worsen auto-PEEP or precipitously drop preload.
Estimated Time:2m 30s
Question 717Question →

An independent 5454-year-old woman is evaluated at a walk-in medical center after experiencing one week of escalating breathlessness. She mentions a newly developed, irritating cough that worsens when she attempts to sleep in her bed, prompting her to sleep propped up in a living room chair. The patient has a known history of essential hypertension and has smoked a pack of cigarettes daily for thirty years. Her vitals indicate a blood pressure of 172/96 mmHg172/96\text{ mmHg}, a pulse of 108/min108\text{/min}, and respirations of 24/min24\text{/min}. Oxygen saturation reads 92%92\% while breathing ambient air. Physical examination reveals distended neck veins when she is seated upright. Auscultating her back reveals widespread crackles at both lung bases that persist despite directed coughing. Cardiac examination is notable for a rapid rate with a clearly audible S3S_3 gallop. Pressing on the skin of her lower legs leaves noticeable indentations bilaterally. Which of the following is the most appropriate initial pharmacologic intervention to relieve this patient's current respiratory symptoms?

Show answer & explanation

Answer: Intravenous furosemide

Answer

Intravenous furosemide is the correct initial pharmacologic intervention.
The correct intervention is intravenous furosemide. This patient is presenting with a classic clinical picture of acute decompensated heart failure (ADHF). She has symptoms of left-sided heart failure (orthopnea, dyspnea, bibasilar lung crackles) and right-sided heart failure (jugular venous distention, lower extremity pitting edema). The presence of an S3S_3 gallop is a highly specific marker for elevated left ventricular filling pressures. Intravenous loop diuretics, such as furosemide, are the first-line pharmacologic therapy to rapidly induce diuresis, decrease intravascular volume, reduce left ventricular preload, and effectively relieve pulmonary congestion and respiratory distress.

Step-by-Step Solution

1
Analyze the patient's symptoms and vital signs.
The patient has progressive dyspnea, orthopnea (sleeping in a chair), hypoxia, tachypnea, and tachycardia.
Identifying the primary clinical syndrome helps narrow down the differential diagnosis between pulmonary and cardiac causes of dyspnea.
2
Evaluate the physical examination findings.
Findings include jugular venous distention, bibasilar crackles, an S3S_3 gallop, and bilateral lower extremity pitting edema.
These are the hallmark signs of left- and right-sided volume overload, confirming a diagnosis of acute decompensated heart failure (ADHF).
3
Determine the most appropriate initial therapy for the diagnosed condition.
Loop diuretics (e.g., intravenous furosemide) are indicated to rapidly reduce volume overload and alleviate pulmonary congestion.
Diuresis directly treats the underlying pathophysiology of ADHF by decreasing left ventricular preload.

Key Concept

The primary initial treatment for acute decompensated heart failure with volume overload (evidenced by orthopnea, JVD, crackles, S3S_3 gallop, and edema) is aggressive diuresis with intravenous loop diuretics.
Question 718Question →

Primary care evaluation is requested for a 52-year-old male reporting four weeks of profound fatigue, night sweats, and unintentional weight loss. The patient underwent an uncomplicated cystoscopy for benign prostatic hyperplasia two months ago. Vital signs include a temperature of 38.2°C (100.8°F), blood pressure of 118/76 mmHg, and a heart rate of 94/min. Physical examination reveals splinter hemorrhages on the bilateral fingernails and a new grade III/VI holosystolic murmur loudest at the cardiac apex. Transesophageal echocardiography demonstrates a 1.4-cm oscillating mass on the anterior leaflet of the mitral valve. Four out of four blood culture bottles grow *Enterococcus faecalis*. Antimicrobial susceptibility testing reveals the following:

AntimicrobialInterpretation
AmpicillinSusceptible
PenicillinSusceptible
VancomycinSusceptible
Gentamicin (High-Level)Resistant
Streptomycin (High-Level)Resistant

Based on the antimicrobial susceptibility results, which of the following is the most appropriate definitive intravenous antibiotic regimen?

Show answer & explanation

Answer: Ampicillin and ceftriaxone

Answer

Ampicillin and ceftriaxone
The correct answer is ampicillin and ceftriaxone. *Enterococcus faecalis* is a classic cause of infective endocarditis following genitourinary manipulation (such as cystoscopy). Successful treatment requires bactericidal activity. Because ampicillin alone is only bacteriostatic against enterococci, it must be combined with a synergistic agent. Historically, synergy was achieved by combining ampicillin with an aminoglycoside (e.g., gentamicin). However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR), meaning aminoglycoside-modifying enzymes completely negate any potential synergy.

To achieve bactericidal activity in HLAR *E. faecalis*, a dual beta-lactam regimen of ampicillin and ceftriaxone is utilized. While enterococci are intrinsically resistant to cephalosporins due to low affinity for specific penicillin-binding proteins (PBPs, primarily PBP5), ampicillin effectively binds PBP4 and PBP5, while ceftriaxone binds PBP2 and PBP3. This complementary saturation of PBPs results in a powerful synergistic bactericidal effect. Notably, because of its equivalent efficacy and lack of nephrotoxicity, ampicillin plus ceftriaxone is now widely considered a first-line therapy for all *E. faecalis* endocarditis cases, even in the absence of HLAR.

Step-by-Step Solution

1
Identify the clinical syndrome
The patient has subacute native valve infective endocarditis, likely seeded from a recent genitourinary procedure.
Establishing the diagnosis determines the requirement for prolonged, bactericidal combination antibiotic therapy.
2
Analyze the microbiologic and susceptibility data
The pathogen is *Enterococcus faecalis*. It is susceptible to beta-lactams (ampicillin, penicillin) but demonstrates high-level resistance to both gentamicin and streptomycin.
To select targeted therapeutic options and rule out ineffective combinations.
3
Evaluate standard treatment protocols in the context of resistance
Standard bactericidal therapy for *E. faecalis* endocarditis historically involves ampicillin plus an aminoglycoside. However, high-level aminoglycoside resistance (HLAR) means synergy is lost, making this combination ineffective.
To prevent the administration of toxic and non-synergistic medications.
4
Select the optimal alternative regimen based on stewardship principles
Ampicillin plus ceftriaxone is selected. This dual beta-lactam regimen provides synergistic bactericidal activity independently of aminoglycoside resistance.
To achieve a targeted, curative outcome while minimizing toxicity and avoiding unnecessarily broad antibiotics like daptomycin.

Key Concept

The definitive treatment of *Enterococcus faecalis* infective endocarditis with high-level aminoglycoside resistance (HLAR) requires dual beta-lactam therapy with ampicillin and ceftriaxone to achieve synergistic bactericidal activity.
Question 719Question →

During an unscheduled visit to a primary care clinic, a 62-year-old retired teacher reports a 3-day history of progressively worsening shortness of breath and a persistent cough. He notes that his sputum has changed from clear to thick and yellow-green over the past 48 hours. His past medical history is significant for chronic obstructive pulmonary disease (COPD), heart failure with preserved ejection fraction (HFpEF), and Hashimoto thyroiditis. His current medications include inhaled tiotropium, oral metoprolol, and oral levothyroxine.

Vital signs are: temperature 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), blood pressure 138/86 mmHg138/86 \text{ mmHg}, pulse 98/min98/\text{min}, and respirations 24/min24/\text{min}. Oxygen saturation is 89%89\% on room air.

Physical examination reveals a patient in mild respiratory distress. Lung auscultation demonstrates a prolonged expiratory phase with diffuse bilateral wheezing. Cardiac auscultation reveals a regular rhythm with normal heart sounds; there is no jugular venous distention and no peripheral edema.

Arterial blood gas analysis on room air reveals:
pH: 7.347.34
PaCO 2_2: 54 mmHg54 \text{ mmHg}
PaO 2_2: 60 mmHg60 \text{ mmHg}
HCO 3−_3^-: 28 mEq/L28 \text{ mEq/L}

Laboratory studies show a leukocyte count of 11,200/mm311,200/\text{mm}^3, a thyroid-stimulating hormone (TSH) level of 3.5 \muU/mL3.5 \text{ \mu U/mL} (normal: 0.5−5.0 \muU/mL0.5-5.0 \text{ \mu U/mL}), and a free T4 of 1.1 ng/dL1.1 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL}).

A chest radiograph displays hyperinflated lungs with flattened diaphragms, but no focal consolidation or pleural effusion.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Prescribe oral azithromycin, nebulized albuterol, and a short course of oral prednisone.

Answer

Prescribe oral azithromycin, nebulized albuterol, and a short course of oral prednisone.
The correct answer provides the standard triad of medical therapy for an acute exacerbation of COPD in the outpatient setting. The patient demonstrates the classic presentation of an AECOPD, defined by an acute change in one or more cardinal symptoms: cough, sputum volume, and sputum purulence. Because he has increased sputum purulence along with increased dyspnea, he meets the criteria for antibiotic therapy. Appropriate initial management includes a short-acting bronchodilator (albuterol), a systemic glucocorticoid (oral prednisone for 5-7 days), and a narrow-spectrum oral antibiotic (such as a macrolide like azithromycin, a tetracycline, or a cephalosporin).

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and physical examination findings.
The patient exhibits increased dyspnea, increased cough, and purulent sputum, with diffuse wheezing and hyperinflated lungs.
These are the cardinal signs of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
2
Evaluate the arterial blood gas and laboratory values.
The ABG reveals acute-on-chronic respiratory acidosis with hypoxemia. TSH and T4 are normal.
This confirms the severity of the respiratory compromise while ruling out a primary metabolic acid-base disorder or a thyroid abnormality as the cause of his fatigue.
3
Determine the appropriate evidence-based interventions for an outpatient AECOPD with purulent sputum.
The standard of care includes short-acting bronchodilators, systemic glucocorticoids (like oral prednisone), and an oral antibiotic (like azithromycin) due to the presence of all three cardinal symptoms.
Antibiotics are specifically indicated in AECOPD when there is increased sputum purulence combined with at least one other cardinal symptom (increased dyspnea or increased sputum volume).

Key Concept

Management of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) involves bronchodilators, systemic glucocorticoids, and antibiotics (if specific criteria are met).
Question 720Question →

A 6262-year-old man is evaluated in the emergency department for severe right knee pain that began abruptly during the night. The patient states the pain is so intense that he cannot bear weight or tolerate the bedsheet touching his knee. His past medical history includes hypertension, diet-controlled type 2 diabetes mellitus, and stage 4 chronic kidney disease with a baseline estimated glomerular filtration rate of 22 mL/min/1.73 m222 \text{ mL/min}/1.73 \text{ m}^2. His current medications are amlodipine and atorvastatin. Vital signs show a temperature of 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure of 145/88 mm Hg145/88 \text{ mm Hg}, and heart rate of 94/min94/\text{min}. Physical examination reveals a markedly swollen, erythematous, and exquisitely tender right knee. A joint aspiration is performed. Synovial fluid analysis shows a leukocyte count of 42,000/mm342,000/\text{mm}^3 with 82%82\% segmented neutrophils. Gram stain of the fluid demonstrates no organisms. Polarized light microscopy reveals the presence of needle-shaped crystals with strong negative birefringence. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intra-articular methylprednisolone

Answer

Intra-articular methylprednisolone
The most appropriate management for this patient is an intra-articular injection of a glucocorticoid such as methylprednisolone. The patient is experiencing an acute monoarticular flare of gout, confirmed by the presence of needle-shaped, negatively birefringent crystals in the synovial fluid. While NSAIDs (e.g., indomethacin) and colchicine are typical first-line oral therapies for acute gout, both are highly problematic in this patient due to his stage 4 chronic kidney disease. NSAIDs can precipitate acute renal failure, and colchicine carries a high risk of severe toxicity due to decreased renal clearance. Because only a single joint is involved and infectious arthritis has been reasonably excluded (negative Gram stain), an intra-articular glucocorticoid injection is the safest and most effective option, offering rapid anti-inflammatory action with minimal systemic absorption.

Step-by-Step Solution

1
Analyze the synovial fluid results.
Fluid shows marked leukocytosis with needle-shaped, negatively birefringent crystals and a negative Gram stain.
This definitively confirms the diagnosis of an acute gout flare and makes a concurrent bacterial infection highly unlikely.
2
Evaluate the patient's medical history and comorbidities.
The patient has stage 4 chronic kidney disease (eGFR of 22 mL/min/1.73 m222 \text{ mL/min}/1.73 \text{ m}^2).
Renal function directly dictates the safety profile of standard gout therapies (NSAIDs, colchicine, and systemic glucocorticoids).
3
Select the safest and most effective targeted pharmacotherapy.
Intra-articular glucocorticoids (methylprednisolone) are chosen.
First-line agents like NSAIDs and colchicine are contraindicated in advanced CKD. A local joint injection provides rapid relief with minimal systemic side effects.

Key Concept

Management of acute gout flares in patients with severe chronic kidney disease.
PreviousPage 36 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 36 | Examkin